Corcept Therapeutics | CORT - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
Acadia Pharmaceuticals USD 44.57M 32.32M 2026-06
Alaunos Therapeutics USD 400K 213K 2026-03
ANI Pharmaceuticals USD 73.83M 4.14M 2026-06
Ardelyx USD 28.2M 8.96M 2026-03
Aurora Cannabis CAD 9.31M 58.72M 2026-03
BioMarin Pharmaceutical USD 913.67M 120.52M 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Canopy Growth CAD 34.82M 14.85M 2026-03
Corcept Therapeutics USD 14.91M 18.4M 2026-06
Eli Lilly USD 6.11B 1.08B 2026-06
J&J USD 9.22B 1.24B 2026-06
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Lexicon Pharmaceuticals USD 3M 87K 2026-03
Merck USD 3.83B 36M 2026-06
Nektar Therapeutics USD 10.03M 744K 2026-03
Novartis USD 4.26B 64M 2026-06
Novartis USD 4.32B 134M 2026-03
Omeros USD 8.84M 4.42M 2025-06
Pacira USD 17.51M 3.5M 2026-06
Pfizer USD 4.58B 75M 2026-06
Supernus Pharmaceuticals USD 5.59M 4.58M 2026-06
TG Therapeutics USD 213.69M 64.85M 2026-06